Grand Junction, COLORADO1 Active Studies

Advanced Solid Tumors Clinical Trials in Grand Junction, COLORADO

Find 1 actively recruiting advanced solid tumors clinical trials in Grand Junction, COLORADO. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
225
Enrolling

Recruiting Advanced Solid Tumors Studies in Grand Junction

About Advanced Solid Tumors Clinical Trials in Grand Junction

Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.

There are currently 1 advanced solid tumors clinical trials recruiting participants in Grand Junction, COLORADO. These studies are seeking a combined 225 participants. Research is being sponsored by Tango Therapeutics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Advanced Solid Tumors Clinical Trials in Grand Junction — FAQ

Are there advanced solid tumors clinical trials in Grand Junction?

Yes, there are 1 advanced solid tumors clinical trials currently recruiting in Grand Junction, COLORADO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Grand Junction?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Grand Junction research site will contact you about next steps.

Are clinical trials in Grand Junction free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Grand Junction studies also compensate for your time and travel.

What advanced solid tumors treatments are being tested?

The 1 active trials in Grand Junction are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.

Data updated March 2, 2026 from ClinicalTrials.gov